C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris - PubMed (original) (raw)
. 2000 Jun;21(12):1000-8.
doi: 10.1053/euhj.1999.1981.
Affiliations
- PMID: 10901512
- DOI: 10.1053/euhj.1999.1981
C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris
M C Tataru et al. Eur Heart J. 2000 Jun.
Abstract
Background: Recent findings provide evidence for the importance of inflammatory processes in the pathogenesis of atherosclerosis. C-reactive protein was elevated in patients with peripheral artery disease, coronary heart disease and myocardial infarction compared to normal subjects.
Methods: In 1112 male and 299 female survivors of myocardial infarction (mean age +/- SD, men, 50.4 +/- 9.5, women, 56.1 +/- 9.3), we investigated whether plasma C-reactive protein concentration is associated with the severity of coronary heart disease and generalized pre-clinical or clinically manifest arteriopathy. The control group consisted of 326 male and 138 female individuals matched for age without clinical symptoms of coronary disease. The severity of arteriosclerotic changes was determined for the extra-cranial brain-supplying arteries, abdominal aorta, pelvis and leg arteries. In myocardial infarction patients coronary angiography was performed. Laboratory analyses included determination of C-reactive protein, fibrinogen, D-dimer, HDL-cholesterol, LDL-cholesterol and triglycerides.
Results: The following ranking of C-reactive protein concentrations was found: controls < or = patients after myocardial infarction without atherosclerosis < or = patients with myocardial infarction and pre-clinical atherosclerosis < or = patients with myocardial infarction and clinically manifest atherosclerosis. Additionally, our data showed a significant association between C-reactive protein concentrations and the angiographically detected degree of coronary heart disease.
Conclusions: As C-reactive protein is a marker of inflammatory processes, our results in patients with clinically manifest and early pre-clinical atherosclerosis support the hypothesis that inflammatory processes in the vessel wall participate in atherogenesis. Moreover, they support the hypothesis of a causal relationship between an acute phase reaction and the pathogenesis of atherosclerosis in coronary arteries and other parts of the arterial vessel system.
Comment in
- C-reactive protein, inflammation and atherosclerosis: do we really understand it yet?
Weintraub WS, Harrison DG. Weintraub WS, et al. Eur Heart J. 2000 Jun;21(12):958-60. doi: 10.1053/euhj.2000.2109. Eur Heart J. 2000. PMID: 10901504 Review. No abstract available.
Similar articles
- D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Tataru MC, Heinrich J, Junker R, Schulte H, von Eckardstein A, Assmann G, Koehler E. Tataru MC, et al. Eur Heart J. 1999 Oct;20(20):1493-502. doi: 10.1053/euhj.1999.1519. Eur Heart J. 1999. PMID: 10493848 - Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Tataru MC, Schulte H, von Eckardstein A, Heinrich J, Assmann G, Koehler E. Tataru MC, et al. Coron Artery Dis. 2001 May;12(3):157-65. doi: 10.1097/00019501-200105000-00001. Coron Artery Dis. 2001. PMID: 11352071 - High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
Koenig W. Koenig W. Int J Cardiol. 2013 Oct 15;168(6):5126-34. doi: 10.1016/j.ijcard.2013.07.113. Epub 2013 Aug 24. Int J Cardiol. 2013. PMID: 23978367 Review. - High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease.
Rosenson RS, Koenig W. Rosenson RS, et al. Curr Opin Cardiol. 2002 Jul;17(4):325-31. doi: 10.1097/00001573-200207000-00001. Curr Opin Cardiol. 2002. PMID: 12151864 Review.
Cited by
- Prognostic impact of baseline high-sensitivity C-reactive protein in patients with acute myocardial infarction undergoing percutaneous coronary intervention based on body mass index.
Ahmed K, Jeong MH, Chakraborty R, Cho KH, Sim DS, Hong YJ, Ahn Y, Hachinohe D, Cho MC, Kim CJ, Kim YJ. Ahmed K, et al. Korean Circ J. 2012 Mar;42(3):164-72. doi: 10.4070/kcj.2012.42.3.164. Epub 2012 Mar 26. Korean Circ J. 2012. PMID: 22493611 Free PMC article. - Relationship Between Carotid Intima-Media Thickness with some Inflammatory Biomarkers, Ghrelin and Adiponectin in Iranians with and without Metabolic Syndrome in Isfahan Cohort Study.
Hajmohammadi T, Sadeghi M, Dashti M, Hashemi M, Saadatnia M, Soghrati M, Talaei M, Sarrafzadegan N. Hajmohammadi T, et al. ARYA Atheroscler. 2010 Summer;6(2):56-61. ARYA Atheroscler. 2010. PMID: 22577415 Free PMC article. - Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin.
Zhong Y, Tang H, Zeng Q, Wang X, Yi G, Meng K, Mao Y, Mao X. Zhong Y, et al. Ups J Med Sci. 2012 Nov;117(4):390-8. doi: 10.3109/03009734.2012.672345. Epub 2012 Sep 25. Ups J Med Sci. 2012. PMID: 23009223 Free PMC article. - Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.
Koc M, Karaarslan O, Abali G, Batur MK. Koc M, et al. Tex Heart Inst J. 2010;37(1):42-8. Tex Heart Inst J. 2010. PMID: 20200626 Free PMC article. - Impact of bleeding during dual antiplatelet therapy in patients with coronary artery disease.
Tung YC, See LC, Chang SH, Liu JR, Kuo CT, Chang CJ. Tung YC, et al. Sci Rep. 2020 Dec 7;10(1):21345. doi: 10.1038/s41598-020-78400-4. Sci Rep. 2020. PMID: 33288822 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials